Myopia, or short-sightedness, is one of the most common causes of sight impairment worldwide. By 2050, five billion people (half the world’s population) will be short sighted, compared to approximately 1.4 billion people today.

People with myopia have relatively long eyes, so that light is focused in front of the retina instead of directly onto it. Since the eye continues to grow throughout childhood, someone who develops myopia as a child will continue to get more short-sighted as they grow older, with a greater risk of sight-threatening complications.

Previous studies performed by Dr Denise Atan and her team at University of Bristol, showed that for each additional year we spend in education, the more myopic we become, on average, as a population. Evidence from other studies suggests that this may be because we spend less time outside, reducing our exposure to natural daylight. Other risk factors for myopia include the time we spend on near work, urbanization, socioeconomic position, diet, pregnancy-related factors and genetics.

Children with myopia tend to engage in less physical activity, but physical activity alone is not protective against myopia. Myopia is more prevalent in countries adopting a Western diet and lifestyle and many of the genes that increase the risk of myopia are involved in insulin/glucose signalling and obesity/fat metabolism. Insulin signalling also appears to influence the normal growth of the eye. As the Western diet tends toward greater consumption of energy-dense foods, one hypothesis is that compensatory increases in blood glucose and insulin levels send increased growth signals to the eyes which become more myopic.

This project aims to determine how genetic and environmental factors interact with insulin signalling to affect myopia. Changes in insulin signalling happen naturally in children around puberty, and so we will use information in the Avon Longitudinal Study of Parents and Children on eye growth, glasses prescriptions, blood levels of glucose and insulin before, during and after puberty on thousands of children followed prospectively from birth, to find out how they interact to affect eye growth.

Additionally, there are normal variants in our genes that influence fasting levels of insulin and glucose and we will find out how these genetic variants are linked to myopia. These analyses should provide novel insights into the relationship between insulin signalling and myopia, and have the potential to identify new targets for treatment.

Please help us continue funding vital research like this to help find new treatments for all eye diseases.